Skip to main content
 
Exosome Diagnostics is pleased to partner with Cal Ripken, Jr. Click here to learn more and follow Cal's journey with us. 

Top navigation

  • Cal Ripken, Jr.
  • GSA Award
  • Provider Resources
  • Contact Us
  • +1 844 396 7663
Bio-Techne Exosome logo

Main navigation

  • Physicians
    • ExoDx™ Prostate Test: At-Home Collection Kit
    • ExoDx™ Prostate Test
    • Challenge of Prostate Cancer
    • Physician FAQs
    • What are Exosomes
    • Publications and Abstracts
  • Patients
    • The ExoDx Prostate Test
    • Understanding PSA Levels
    • About Prostate Cancer
    • ZERO - The End of Prostate Cancer
    • Patient FAQs
    • Patient Assistance Program
    • Billing Information
  • Pharma Services
    • Working with Us
    • Biomarker Discovery
    • Assay Development
    • Exosome Enrichment Capabilities
    • Companion Diagnostics (CDx) and Clinical Trial Support
  • Our Technology
    • Our Technology
    • Sensitivity to RNA/DNA
    • Extraction Procedures
    • Superiority to cfDNA and CTCs
  • News & Events
    • News
    • Press
    • Webinars
    • Events

Top navigation

  • Cal Ripken, Jr.
  • GSA Award
  • Provider Resources
  • Contact Us
  • +1 844 396 7663

Press

  • Exosome Diagnostics Launches National Sales Team to Support Flagship Test, ExoDx®Prostate(IntelliScore)

    Press Jan 04, 2018

  • Exosome Diagnostics Publishes a Study Demonstrating Superior Performance of ExoLution™ Plus Liquid Biopsy Platform in Lung Cancer

    Press Dec 19, 2017

  • Exosome Diagnostics Executes Coverage Agreement for its EPI Test with Three Rivers Provider Network

    Press Dec 04, 2017

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4

(844) 396-7663
exosomedx.info@bio-techne.com
266 Second Ave, Suite 200
Waltham, MA 02451

Footer menu

  • About Bio-Techne
  • Management Team
  • Careers
  • Investors
  • Corporate Responsibility
  • Accreditation and Licensure

Social navigation

  • Facebook
  • Twitter
  • LinkedIn

Iso LogoThis test was evaluated and its performance characteristics determined by Exosome Diagnostics, Inc. Exosome Diagnostics is certified under the Clinical Laboratory Improvement Amendments (CLIA) Act of 1988 as qualified to perform high complexity clinical testing. CLIA number: 22D2093470.  Exosome Diagnostics and ExoDx are registered trademarks of Exosome Diagnostics, Inc.

© 2020 ExoDx

Bottom footer navigation

  • Privacy Policy